WIP null mice display a progressive immunological disorder that resembles Wiskott-Aldrich syndrome

Journal of Pathology

Volumn 211, Issue 1, 2007, Pages 67-75

  Curcio, C ^d   Pannellini, T ^b   Lanzardo, S ^a   Formi, G ^a   Musiani, P ^b   Anton I M ^c  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d NONE

Author keywords

Immunodeficiency; WAS; WAS protein; WASP; WASP interacting protien; WIP; WIP null mice; Wiskott Aldrich syndrome

Indexed keywords

AUTOANTIBODY; BINDING PROTEIN; IMMUNOGLOBULIN A; UNCLASSIFIED DRUG; WISKOTT ALDRICH SYNDROME PROTEIN; WISKOTT ALDRICH SYNDROME PROTEIN INTERACTING PROTEIN;

ANATOMICAL VARIATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CONTROLLED STUDY; DISEASE ASSOCIATION; ERYTHROPOIESIS; FEMALE; GRANULOCYTOSIS; HEMATOPOIETIC TISSUE; IMMUNOPATHOLOGY; INTERSTITIAL PNEUMONIA; KIDNEY DISEASE; LYMPH NODE; LYMPHOPOIESIS; MALE; MOUSE; NONHUMAN; PATHOLOGICAL ANATOMY; PEYER PATCH; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SPLENOMEGALY; ULCERATIVE COLITIS; WISKOTT ALDRICH SYNDROME;

ANIMALS; ARTHRITIS; AUTOANTIBODIES; B-LYMPHOCYTES; CARRIER PROTEINS; COLITIS, ULCERATIVE; ERYTHROCYTE COUNT; FEMALE; FLOW CYTOMETRY; GLOMERULONEPHRITIS; INTESTINES; KIDNEY; LUNG; LUNG DISEASES, INTERSTITIAL; LYMPH NODES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, ANIMAL; PLATELET COUNT; SPLEEN; WISKOTT-ALDRICH SYNDROME; WISKOTT-ALDRICH SYNDROME PROTEIN;

EID: 33846260575     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2088     Document Type: Article

References (34)

1. Aldrich RA, Steinberg AG, Campbell DC. Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. Pediatrics 1954;13:133-139.
2. Rosen FS, Cooper MD, Wedgwood RJ. The primary immunodeficiencies. N Engl J Med 1995;333:431-440.
3. Burns S, Cory GO, Vainchenker W, Thrasher AJ. Mechanisms of WASp-mediated hematologic and immunologic disease. Blood 2004;104:3454-3462.
4. Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 1994;78:635-644.
5. Thrasher AJ. WASp in immune-system organization and function. Nat Rev Immunol 2002;2:635-646.
6. Stewart DM, Tian L, Nelson DL. Mutations that cause the Wiskott-Aldrich syndrome impair the interaction of Wiskott-Aldrich syndrome protein (WASP) with WASP interacting protein. J Immunol 1999;162:5019-5024.
7. Volkman BF, Prehoda KE, Scott JA, Peterson FC, Lim WA. Structure of the N-WASP EVH1 domain-WIP complex: insight into the molecular basis of Wiskott-Aldrich syndrome. Cell 2002;111:565-576.
8. Imai K, Nonoyama S, Ochs HD. WASP (Wiskott-Aldrich syndrome protein) gene mutations and phenotype. Curr Opin Allergy Clin Immunol 2003;3:427-436.
9. Kim MK, Kim ES, Kim DS, Choi IH, Moon T, Yoon CN, et al. Two novel mutations of Wiskott-Aldrich syndrome: the molecular prediction of interaction between the mutated WASP L101P with WASP-interacting protein by molecular modeling. Biochim Biophys Acta 2004;1690:134-140.
10. Ramesh N, Anton IM, Hartwig JH, Geha RS. WIP, a protein associated with Wiskott-Aldrich syndrome protein, induces actin polymerization and redistribution in lymphoid cells. Proc Natl Acad Sci USA 1997;94:14671-14676.
11. Donnelly SF, Pocklington MJ, Pallotta. D, Orr E. A proline-rich protein, verprolin, involved in cytoskeletal organization and cellular growth in the yeast Saccharomyces cerevisiae. Mol Microbiol 1993;10:585-596.
12. Anton IM, Jones GE. WIP: a multifunctional protein involved in actin cytoskeleton regulation. Eur J Cell Biol 2006;85:295-304.
13. Anton IM, de la Fuente MA, Sims TN, Freeman S, Ramesh N, Hartwig JH, et al. WIP deficiency reveals a differential role for WIP and the actin cytoskeleton in T and B cell activation. Immunity 2002;16:193-204.
14. Kettner A, Kumar L, Anton IM, Sasahara Y, de la Fuente M, Pivniouk VI, et al. WIP regulates signaling via the high affinity receptor for immunoglobulin E in mast cells. J Exp Med 2004;199:357-368.
15. Haas M. Histology and immunohistology of IgA nephropathy. J Nephrol 2005;18:676-680.
16. Ogueta S, Olazabal I, Santos I, Delgado-Baeza E, Garcia-Ruiz JP. Transgenic mice expressing bovine GH develop arthritic disorder and self-antibodies. J Endocrinol 2000;165:321-328.
17. Anton IM, Saville SP, Byrne MJ, Curcio C, Ramesh N, Hartwig JH, et al. WIP participates in actin reorganization and ruffle formation induced by PDGF. J Cell Sci 2003;116:2443-2451.
18. Gallego MD, de la Fuente MA, Anton IM, Snapper S, Fuhlbrigge R, Geha RS. WIP and WASP play complementary roles in T cell homing and chemotaxis to SDF-1alpha. Int Immunol 2006;18:221-232.
19. Su TT, Guo B, Wei B, Braun J, Rawlings DJ. Signaling in transitional type 2 B cells is critical for peripheral B-cell development. Immunol Rev 2004;197:161-178.
20. Lopes-Carvalho T, Kearney JF. Development and selection of marginal zone B cells. Immunol Rev 2004;197:192-205.
21. Snapper SB, Rosen FS, Mizoguchi E, Cohen P, Khan W, Liu CH, et al. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity 1998;9:81-91.
22. Vermi W, Blanzuoli L, Kraus MD, Grigolato P, Donato F, Loffredo G, et al. The spleen in the Wiskott-Aldrich syndrome: histopathologic abnormalities of the white pulp correlate with the clinical phenotype of the disease. Am J Surg Pathol 1999;23:182-191.
23. Calle Y, Chou HC, Thrasher AJ, Jones GE. Wiskott-Aldrich syndrome protein and the cytoskeletal dynamics of dendritic cells. J Pathol 2004;204:460-469.
24. Westerberg L, Larsson M, Hardy SJ, Fernandez C, Thrasher AJ, Severinson E. Wiskott-Aldrich syndrome protein deficiency leads to reduced B-cell adhesion, migration, and homing, and a delayed humoral immune response. Blood 2005;105:1144-1152.
25. Park JY, Shcherbina A, Rosen FS, Prodeus AP, Remold-O'Donnell E. Phenotypic perturbation of B cells in the Wiskott-Aldrich syndrome. Clin Exp Immunol 2005;139:297-305.
26. Molina IJ, Sancho J, Terhorst C, Rosen FS, Remold-O'Donnell E. T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses. J Immunol 1993;151:4383-4390.
27. Gallego MD, Santamaria M, Pena J, Molina IJ. Defective actin reorganization and polymerization of Wiskott-Aldrich T cells in response to CD3-mediated stimulation. Blood 1997;90:3089-3097.
28. Rengan R, Ochs HD, Sweet LI, Keil ML, Gunning WT, Lachant NA. et al. Actin cytoskeletal function is spared, but apoptosis is increased, in WAS patient hematopoietic cells. Blood 2000;95:1283-1292.
29. Akman IO, Ostrov BE, Neudorf S. Autoimmune manifestations of the Wiskott-Aldrich syndrome. Semin Arthritis Rheum 199827:218-225.
30. Folwaczny C, Ruelf, C, Walther J, Konig A, Emmerich B. Ulcerative colitis in a patient with Wiskott-Aldrich syndrome. Endoscopy 2002;34:840-941.
31. DeSanto NG, Sessa A, Capodicasa G, Merom M, Capasso G, Esposito L, et al. IgA glomerulonephritis in Wiskott-Aldrich syndrome. Child Nephrol Urol 1988-89;9:118-120.
32. Lasseur C, Allen AC, Deminiere C, Aparicio M, Feehally J, Combe C. Henoch-Schonlein purpura with immunoglobulin A nephropathy and abnormalities of immunoglobulin A in a Wiskott-Aldrich syndrome carrier. Am J Kidney Dis 1997;29:285-287.
33. Matsukura H, Kanegane H, Miya K, Ohtsubo K, Higuchi A, Tanizawa T, et al. IgA nephropathy associated with X-linked thrombocytopenia. Am J Kidney Dis 2004;43:e7-e12.
34. Schurman SH, Candotti F. Autoimmunity in Wiskott-Aldrich syndrome. Curr Opin Rheumatol 2003;15:446-453.